Furthermore, GH levels decrease also during ageing [141] and are generally lower in males compared to females [149], which fits to the strongly increased risk for a severe COVID-19 development in older patients [150] and to the higher risk of male patients [151–153]. Here, GH1 is linked to COVID-19.